Semaglutide, other GLP-1 receptor agonists continue taking the world by storm GLP-1 receptor agonists are now being used to treat obese and overweight patients throughout the United States
Net peptide content and purity are established by reverse-phase HPLC, with identity confirmed by mass spectrometry, and every lot ships with an independent Certificate of Analysis
Bacteriostatic Water, with its ability to prevent bacterial contamination and multi-use nature, stands out as the superior choice
This ratio is consistent with what most pharmacological weight loss interventions produce, though it is slightly more favorable toward fat loss than what surgical interventions typically achieve
However, a recently published case report demonstrated semaglutide-induced lupus erythematosus with multiple organ involvement [289]
Shelise Edwards, MD, FACEP, is a board-certified emergency medicine physician